Tobira to Sell to Allergan for $1.7 Billion

Washington, DC – September 21, 2016 – Cooley serves as Tobira Therapeutics' intellectual property counsel and acted as such, performing IP diligence on its behalf, for its sale to Allergan for up to $1.7 billion. The price was approximately 19x Tobira’s value at the time of the deal. 

"I am extremely excited to see Tobira and Allergan come together," said Laurent Fischer, MD, CEO, Tobira Therapeutics in a company issued press release. "The combination of our team's innovation in the NASH (non-alcoholic steatohepatitis) space and the infrastructure, development expertise and world-class ability of Allergan to market medicines will enable us to more rapidly develop and commercialize needed medications for patients suffering from NASH and other serious fibrotic diseases around the world."

Tobira is a clinical-stage biopharmaceutical company focused on the development and commercialization of therapies for NASH and other liver diseases. Allergan focuses on developing, manufacturing and commercializing branded pharmaceuticals, devices and biologic products.

Cooley has the largest life sciences patent team in the US and is routinely tapped to handle the IP diligence aspects of high-value investments, M&A deals, capital market offerings and other transactions.

About Cooley LLP

Clients partner with Cooley on transformative deals, complex IP and regulatory matters, and high-stakes litigation, where innovation meets the law. 

Cooley has 900 lawyers across 12 offices in the United States, China and Europe.

This content is provided for general informational purposes only, and your access or use of the content does not create an attorney-client relationship between you or your organization and Cooley LLP, Cooley (UK) LLP, or any other affiliated practice or entity (collectively referred to as “Cooley”). By accessing this content, you agree that the information provided does not constitute legal or other professional advice. This content is not a substitute for obtaining legal advice from a qualified attorney licensed in your jurisdiction and you should not act or refrain from acting based on this content. This content may be changed without notice. It is not guaranteed to be complete, correct or up to date, and it may not reflect the most current legal developments. Prior results do not guarantee a similar outcome. Do not send any confidential information to Cooley, as we do not have any duty to keep any information you provide to us confidential. This content may be considered Attorney Advertising and is subject to our legal notices.